UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
[Exclusive] MSD Korea playing tricks to reduce daycare cost
by Kim Yun-mi
2019-05-09 11:20
T&R Biofab, CiSTEM to co-develop rare disease treatments
by Lee Han-soo
2019-05-09 11:17
‘GC Wellbeing’s placenta injection has liver regenerative effects’
by Lee Han-soo
2019-05-08 17:07
Celgene’s myelodysplastic syndrome treatment gets more insurance benefits
by Lee Han-soo
2019-05-07 17:36
GC Cell to start developing CAR-T treatment for pancreatic cancer
by Lee Han-soo
2019-05-07 16:10
라인
FDA OKs Gemvax & Kael's Alzheimer treatment for P2 trials
by Lee Han-soo
2019-05-07 16:09
[Exclusive] MSD workers appalled by executive’s remarks on childcare leave
by Jeong Sae-im
2019-05-07 12:08
Dong-A ST posts robust Q1 profit
by Lee Han-soo
2019-05-03 16:49
Leading hepatitis C drug wins FDA nod for adolescents
by Kim Yun-mi
2019-05-03 15:51
GC surpasses 200-million mark in flu vaccine production
by Lee Han-soo
2019-05-03 14:39
라인
Hanmi's short bowel syndrome treatment becomes orphan drug in US
by Lee Han-soo
2019-05-03 11:42
Ministry OKs Lilly Korea’s metastatic breast cancer treatment
by Lee Han-soo
2019-05-02 18:11
GC marks sluggish sales in Q1
by Lee Han-soo
2019-05-02 14:30
Daewoong logs ₩238.1 billion sales in Q1
by Lee Han-soo
2019-05-02 14:09
‘MSD Korea’s monitoring program might be privacy breach’
by Kim Yun-mi
2019-05-02 11:00
라인
Hanmi posts ₩274 billion in Q1 sales
by Lee Han-soo
2019-05-02 10:59
HanAll unveils P2 trial results at ARVO 2019
by Lee Han-soo
2019-04-30 16:31
Drugmakers brace for vaccine shortage amid surging hepatitis A cases
by Kim Yun-mi
2019-04-30 13:13
Daewoong gets positive reviews of its BTX in EU
by Lee Han-soo
2019-04-29 16:13
Yuyu releases research results for dry eye treatment in Canada
by Lee Han-soo
2019-04-29 14:33
-
이전
41
42
43
44
45
46
47
48
49
50
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top